
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical cream containing zinc sulfate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing zinc sulfate are listed in injection and solution forms, all for intravenous use. No zinc sulfate product of any kind is listed in cream form.
This dose form is water-containing (aqueous). Under USP <795>, aqueous preparations carry shorter default beyond-use dates than nonaqueous ones, and a preservative in the base allows a longer date than no preservative. The date printed on the label is the one to follow.
Zinc sulfate supplies the essential mineral zinc by vein or by mouth, and a pharmacy may compound it when a prescriber orders it.
Zinc is an essential trace element the body needs for the activity of hundreds of enzymes, immune function, protein and DNA synthesis, wound healing, and taste and smell. Zinc sulfate is one of the zinc salts used in dietary supplements. Manufactured Zinc Sulfate Injection is indicated in adults and children as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient or contraindicated. Low zinc can cause slow growth, hair loss, diarrhea, poor appetite, slow wound healing and impaired taste. People with digestive disorders such as celiac disease, people who have had bariatric surgery, vegetarians and people with alcohol use disorder are at higher risk. A prescriber might order zinc sulfate compounded in a strength, dosage form or combination that is not manufactured. Compounded preparations are not FDA-approved and require a prescription.
Zinc Sulfate Injection has no boxed warning and should not be used by anyone allergic to zinc. Its label warns of pulmonary embolism from particles that can form in intravenous nutrition, vein damage, aluminum toxicity in people with kidney problems and in preterm infants, copper deficiency and allergic reactions. By mouth, too much zinc can cause nausea, vomiting, stomach cramps, diarrhea, headache and loss of appetite, and long-term excess can lower copper levels and immune function. MedlinePlus notes that zinc nasal sprays and gels may cause loss of smell. Zinc can reduce absorption of quinolone and tetracycline antibiotics and of penicillamine, so doses need to be spaced apart, and thiazide diuretics increase zinc loss in urine. Zinc is a normal part of breast milk, and the injection label does not expect harm to a breastfed infant at the approved dose. Talk to your prescriber or pharmacist about side effects.
Zinc is a cofactor for enzymes including DNA and RNA polymerases, alcohol dehydrogenase and alkaline phosphatases, and coordinates protein folding such as zinc finger motifs. Over 85% of total body zinc resides in skeletal muscle and bone; in blood it is mainly in erythrocytes, and about 80% of serum zinc is bound to albumin, with the rest bound to alpha2-macroglobulin and amino acids. Zinc is eliminated mainly in feces, with smaller urinary losses and losses through hair, skin and sweat. Supplemental iron taken with zinc can reduce zinc absorption. Labeled indication: source of zinc for parenteral nutrition (Zinc Sulfate Injection). The label calls for monitoring zinc concentrations, fluid and electrolyte status, serum osmolarity, blood glucose, liver and kidney function, blood counts and coagulation; if signs of copper deficiency develop, interrupt treatment and check zinc, copper and ceruloplasmin; stop the infusion and evaluate if pulmonary distress occurs. Compounded oral or topical zinc sulfate preparations have no FDA-approved indication. Dosing is per prescriber. Space zinc from quinolones, tetracyclines and penicillamine. Chronic excessive use of zinc-containing denture adhesive creams has been linked to neurological symptoms and anemia.
Wash your hands. Apply the amount on your label to clean, dry skin and rub it in gently. For a metered pump, each press delivers a set amount; your label states how many presses. For transdermal creams, apply to the area your label names and let it dry before dressing. Wash your hands afterward and avoid skin-to-skin contact with others at the application site until it has absorbed. Do not apply to broken skin unless told to.
Creams are aqueous. Under USP <795>, a preserved cream usually carries a beyond-use date of up to 35 days at room temperature or refrigerated, and an unpreserved one 14 days refrigerated. Follow the storage line on your label, keep from freezing, keep out of reach of children, and discard after the beyond-use date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)